博济医药(300404.SZ)：上半年净利润1556.99万元 同比下降48.33%

Core Insights - The company reported a revenue of 361 million yuan for the first half of 2025, representing a year-on-year growth of 5.88% [1] - The net profit attributable to shareholders decreased to 15.57 million yuan, a decline of 48.33% year-on-year [1] - The net profit attributable to shareholders after excluding non-recurring gains and losses was 11.99 million yuan, down 53.28% year-on-year [1] - The basic earnings per share stood at 0.0407 yuan [1]